NOCTI Health: HIV Prevention & Access
How to Get PrEP for $0—and Protect Your Privacy—in 2026
Insurance, manufacturer assistance, state PrEP programs and ADAP do different jobs. This guide shows where to start, what safe prescribing looks like and how to reduce billing surprises.

First: PrEP, PEP and HIV treatment are three different lanes
PrEP is medicine used before possible exposure to prevent HIV. PEP is an emergency course started after a possible exposure. HIV treatment is for a person who has HIV. The programs that pay for one lane may not pay for another, so choosing the correct door matters more than memorizing a coupon name. If a possible exposure happened within the last 72 hours, do not spend the day comparison-shopping assistance programs. CDC says PEP should be evaluated urgently and started as soon as possible—ideally within 24 hours and no later than 72 hours. Contact a clinician, urgent care center or emergency department now. PrEP is not a substitute for that time-sensitive evaluation. This is a U.S. access guide, checked October 22, 2026. Benefits, formularies, income limits and privacy rules can change. It is general education, not medical, insurance, immigration or legal advice.
The fastest map: choose your situation
Have private insurance? Start with the plan’s PrEP benefit and an in-network prescriber. Most non-grandfathered private plans must cover recommended PrEP and integral support services without cost-sharing, but coding mistakes, networks and exceptions can still create bills. Have Medicare? Medicare Part B currently covers FDA-approved oral and injectable PrEP, administration, counseling and specified screening without deductibles, copayments or coinsurance for eligible people at increased risk. Have Medicaid? Medicaid Alternative Benefit Plans—including coverage used for the expansion population—must cover USPSTF A- and B-rated preventive services such as PrEP without cost-sharing. Other Medicaid benefit structures and state implementation can differ, so verify the medication, clinic and lab coverage with the state plan. No insurance? Try an HRSA-funded health center, local health department, sexual-health clinic, Planned Parenthood affiliate where available, a state PrEP assistance program or an eligible manufacturer program. Ask separately about the medication, visit, laboratory work and injection-administration fee. “Free drug” does not automatically mean “free care.”
What the Supreme Court decision did—and did not do
In Kennedy v. Braidwood Management, the U.S. Supreme Court ruled 6–3 in June 2025 that the way members of the U.S. Preventive Services Task Force are appointed does not violate the Constitution. The Court reversed the lower-court judgment that threatened the ACA preventive-services structure. PrEP was central to the dispute because the USPSTF gives effective PrEP an A recommendation for people at increased risk of acquiring HIV. The practical result is that the federal preventive-services framework remains in place. It does not mean every claim will process correctly, every plan is covered by the same rule or every brand is automatically approved without paperwork. Grandfathered plans and some coverage arrangements can work differently, and out-of-network care may produce costs. Before the visit, ask the insurer: “Is this prescriber in network, which PrEP options are covered, and are the baseline and monitoring services coded as preventive?”
Manufacturer assistance: useful, specific and easy to misunderstand
Gilead Advancing Access has two broad paths. Eligible people with commercial insurance may use a co-pay savings program. Gilead’s current Descovy information says the benefit can cover up to $7,200 per year; the current Yeztugo brochure says up to $8,000 per year, including limited help with an injection-administration co-pay. Government-sponsored drug coverage such as Medicare, Medicaid, VA or TRICARE generally makes a person ineligible for these co-pay cards. The separate Medication Assistance Program may provide eligible Gilead prevention medication at no charge. HIV.gov’s current assistance table lists a household-income ceiling of 500% of the federal poverty level for Descovy assistance, while the program can request income and other documentation. Gilead’s current U.S. access page lists Descovy, Truvada and Yeztugo among select supported medicines, subject to program rules. That is why an old post saying a particular medicine was permanently removed should not be treated as today’s eligibility decision—check the live program or call 1-800-226-2056. Manufacturer help may cover the medicine without covering every visit, test or pharmacy complication. Ask for a written estimate covering all four: prescription, clinician, laboratory and administration.
Ready, Set, PrEP is not the current answer for a new applicant
The federal Ready, Set, PrEP program stopped accepting new enrollments on July 30, 2024. California’s public-health notice said people already enrolled could continue at that time, while new applicants needed another pharmaceutical assistance program. A directory or telehealth page that still presents Ready, Set, PrEP as an open national enrollment path is using stale information. Do not replace one outdated shortcut with another. State PrEP programs change, drug formularies change and manufacturer terms change. NASTAD’s PrEP assistance directory, HIV.gov resources, a local benefits navigator and the official program itself are better starting points than an old screenshot. Ask the navigator to confirm the application date, income rule, residency rule, covered services and renewal schedule.
ADAP is treatment assistance—not a PrEP program
The AIDS Drug Assistance Program, or ADAP, is part of Ryan White HIV/AIDS Program Part B. HRSA says ADAP provides FDA-approved medications to low-income people diagnosed with HIV who have limited or no health insurance. States and territories set financial and residency criteria, choose formularies and verify eligibility. Some programs can also purchase insurance or help with coverage-related costs. The word “AIDS” in the name does not mean a person must have AIDS; HRSA’s medical eligibility requirement is an HIV diagnosis. But a person who is HIV-negative and seeking prevention does not use ADAP for PrEP. Look instead for a state PrEP assistance program, health center, insurer benefit or manufacturer assistance. California, for example, operates a separate PrEP Assistance Program. If a test is positive or an HIV diagnosis is confirmed, connect to care promptly. HIV.gov says Ryan White services can help eligible low-income people with HIV who are uninsured or whose insurance does not cover needed care. A case manager can explain the state-specific application instead of asking you to reverse-engineer it from five websites.
| Situation | Best first door | Important limitation |
|---|---|---|
| Possible HIV exposure within 72 hours | Urgent PEP evaluation | Do not wait for a PrEP assistance application |
| HIV-negative and seeking prevention | Insurance PrEP benefit, state PrEP program, health center or manufacturer help | ADAP is not a PrEP program |
| Commercial insurance with a PrEP co-pay | Plan benefit plus an eligible manufacturer co-pay program | Government insurance is generally excluded from manufacturer co-pay cards |
| No insurance | Health center or sexual-health clinic plus state/manufacturer assistance | Free medicine may not cover visits and labs |
| Diagnosed with HIV and limited coverage | Ryan White clinic and state ADAP | Eligibility and formulary vary by state |
| Privacy concern on someone else’s plan | Ask insurer about confidential communications before submitting claims | An EOB or portal activity may reveal care |
Programs change. Verify current eligibility, covered services, renewal rules and privacy practices directly before relying on any route.
Safe PrEP is more than a prescription in the mail
A legitimate PrEP service confirms that you do not have HIV before starting. CDC also recommends baseline STI screening. For oral tenofovir-based PrEP, kidney function must be assessed; hepatitis B screening matters because stopping oral emtricitabine/tenofovir can reactivate hepatitis B. Descovy also calls for lipid assessment. Injectable cabotegravir does not require kidney monitoring, but it has its own injection and HIV-testing schedule. Yeztugo requires HIV testing before initiation and before every six-month injection. For daily oral PrEP, CDC recommends HIV antigen/antibody and HIV-1 RNA testing at least every three months, with no more than a 90-day refill before the next HIV test. Cabotegravir follow-up is one month after the first injection and then at least every two months beginning in month three. Yeztugo is given every six months after initiation, with HIV testing before each injection and as clinically appropriate. The useful red flag is not “this service is online.” Telehealth can be legitimate. The red flag is medication without appropriate HIV testing, no plan for required monitoring, no licensed prescriber, a pharmacy that cannot be verified or pressure to ignore a reactive or unclear result.
| PrEP method | Current core follow-up | Key monitoring point |
|---|---|---|
| Daily oral F/TDF or F/TAF | HIV testing at least every 3 months | Kidney monitoring; hepatitis B screening; lipids for F/TAF |
| Injectable cabotegravir | Month 1, then at least every 2 months beginning in month 3 | HIV testing with injection visits; kidney assessment is not required for CAB |
| Injectable lenacapavir (Yeztugo) | Continuation injection every 6 months | Confirm HIV-negative status before each injection |
A clinician may recommend additional testing based on symptoms, age, kidney risk, anatomy, exposures, medication history or an unclear result.
Privacy: reduce exposure; do not promise invisibility
An Explanation of Benefits can show the provider, date, billed amount and other claim details to the policyholder. If you are covered through a parent, spouse or partner, ask the insurer before care how EOBs are delivered and whether you can request confidential communications at another address, email or portal. Federal HIPAA rules require health plans to accept requests; a plan must accommodate a reasonable request when the person says disclosure could endanger them. State law may provide additional protection. Paying a provider in full without submitting the service to insurance can offer stronger control. HHS says that when protected information relates only to an item or service paid in full out of pocket, and disclosure to the health plan would be for payment or operations and is not otherwise required by law, the provider must agree to a requested restriction. Make the request explicitly and in writing before information is sent. This rule does not erase other lawful disclosures or records. Use your own email, phone number, mailing address and patient-portal settings when possible. Ask how a telehealth service labels packages, charges cards, sends reminders and shares information with laboratories and pharmacies. “Discrete packaging” is not the same as no data trail.
A five-minute quality and cost check
Before enrolling or paying, ask: 1. Is the prescriber licensed in the state where I am physically located for the visit? Verify through the state licensing board. 2. Which PrEP option fits me, and what baseline tests are required for that option? 3. Who orders, performs and pays for follow-up testing—and on what schedule? 4. What is the complete cost for medicine, visits, labs and injections after insurance or assistance? 5. Which licensed pharmacy dispenses the medication? 6. What happens if an HIV result is reactive, an injection is late or kidney function changes? 7. Will an EOB, package, portal notification or credit-card description reveal the service? 8. Can I download my prescription history and laboratory results? Independent reviews can reveal service problems, but Reddit and Trustpilot do not verify medical quality. Use them as clues, then verify licensure, clinical process, pharmacy and program terms through official sources.
The NOCTI Health rule: find the right door, then verify the care
NOCTI can help people discover health resources and providers, but a directory listing is not medical advice, eligibility approval, a license guarantee or proof that a program will cost $0. Confirm the clinician, laboratory, pharmacy, price, privacy practice and current assistance terms directly. Never send identity, immigration, insurance or HIV documents to an unrelated provider or through an unsecured directory message. The simplest decision tree is still the best one: • Possible exposure within 72 hours: urgent PEP evaluation now. • HIV-negative and planning ongoing prevention: PrEP clinician plus the matching insurance or assistance route. • Diagnosed with HIV: treatment provider, Ryan White clinic and state ADAP review. • Privacy concern: ask about EOBs before using insurance, request confidential communications and discuss full self-pay restriction with the provider when appropriate. Cost should not be the reason someone guesses with HIV prevention or stops treatment. Use a navigator, keep copies of results and ask every program to explain the entire path—not only the free-looking square in the middle.
Sources
- CDC HIV Nexus: current clinical guidance and monitoring schedules for PrEP ↗
- CDC HIV Nexus: PEP should start as soon as possible and no later than 72 hours ↗
- CMS: Medicare Part B PrEP coverage and zero cost-sharing ↗
- CMS: ACA implementation FAQ on PrEP medication and integral support services ↗
- CMS: Medicaid strategies and PrEP coverage requirements ↗
- U.S. Supreme Court: Kennedy v. Braidwood Management opinion ↗
- California Department of Public Health: Ready, Set, PrEP stopped new enrollment ↗
- Gilead: current U.S. patient access programs and supported medicines ↗
- Gilead: Descovy PrEP co-pay support information ↗
- Gilead: Yeztugo Advancing Access patient brochure ↗
- FDA: Yeztugo prescribing information, HIV testing and six-month dosing ↗
- HIV.gov: current manufacturer assistance amounts and income criteria ↗
- HRSA: Ryan White Part B AIDS Drug Assistance Program ↗
- HIV.gov: locate Ryan White HIV care and HRSA health centers ↗
- HHS: HIPAA restrictions when a patient pays in full out of pocket ↗
- HHS: requests for confidential health communications ↗
- California Department of Insurance: what an Explanation of Benefits can show ↗
The right program depends on the right first question.
Start with whether you need emergency PEP, ongoing PrEP or HIV treatment. Then use official locators and confirm cost, testing and privacy directly with the clinic or program.
Find PrEP & PEP Services